SARA
HERNANDO REVILLA
INVESTIGADOR/A DOCTOR/A
Publications (10) SARA HERNANDO REVILLA publications
2023
-
Extracellular vesicles released by hair follicle and adipose mesenchymal stromal cells induce comparable neuroprotective and anti-inflammatory effects in primary neuronal and microglial cultures
Cytotherapy, Vol. 25, Núm. 10, pp. 1027-1032
-
Targeting the central nervous system: From synthetic nanoparticles to extracellular vesicles—Focus on Alzheimer's and Parkinson's disease
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, Vol. 15, Núm. 5
2022
-
Dual effect of TAT functionalized DHAH lipid nanoparticles with neurotrophic factors in human BBB and microglia cultures
Fluids and Barriers of the CNS, Vol. 19, Núm. 1
2021
-
Polycaprolactone hybrid scaffolds combining 3D printing and electrospinning to guide the osteogenic differentiation of MC3T3 preosteoblasts for bone tissue regeneration
RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 30-32
2020
-
Nanostructured lipid carriers made of Ω-3 polyunsaturated fatty acids: In vitro evaluation of emerging nanocarriers to treat neurodegenerative diseases
Pharmaceutics, Vol. 12, Núm. 10, pp. 1-22
2019
-
Beneficial effects of n-3 polyunsaturated fatty acids administration in a partial lesion model of Parkinson's disease: The role of glia and NRf2 regulation
Neurobiology of Disease, Vol. 121, pp. 252-262
2018
-
Intranasal administration of TAT-conjugated lipid nanocarriers loading GDNF for Parkinson’s disease
Molecular Neurobiology, Vol. 55, Núm. 1, pp. 145-155
-
The role of lipid nanoparticles and its surface modification in reaching the brain: An approach for neurodegenerative diseases treatment
Current Drug Delivery, Vol. 15, Núm. 9, pp. 1218-1220
2017
-
Nanotechnology based approaches for neurodegenerative disorders: Diagnosis and treatment
Drug and Gene Delivery to the Central Nervous System for Neuroprotection: Nanotechnological Advances (Springer International Publishing), pp. 57-87
2016
-
Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases
Nanomedicine, Vol. 11, Núm. 10, pp. 1267-1285